Latest Announcements

Huntington's Disease, Investor Announcement

The Lancet Neurology publishes Prana’s Huntington’s Disease Trial

The results of Prana’s Phase 2 trial in Huntington’s disease, Reach2HD, has been published in The Lancet Neurology, one of the world’s leading medical journals.


Alzheimer's disease

Prana’s Founding Scientist and CSA publishes landmark paper in Nature

A new report studying Alzheimer’s disease and co-authored by Professor Rudy Tanzi has been published by the respected journal Nature.


Movement disorders expert Professor Ira Shoulson joins Prana Biotechnology's Board of Directors

Email Newsletter

Receive regular updates from Prana Biotechnology by entering your details below and clicking "Subscribe"